Stifel Maintains Bullish View on Intrexon (XON) Following Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Intrexon Announces Third Quarter 2015 Financial Results
November 9, 2015 4:05 PM ESTGERMANTOWN, Md., Nov. 9, 2015 /PRNewswire/ --Â Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced its third quarter results for 2015.Â
Business Highlights and Recent Developments:
During the third quarter, Intrexon and the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, furthered research and development efforts with the collaboration's first two chimeric antigen receptor (CAR) T-cell targets of interest and are advancing these targets to... More